Real-time, aptamer-based tracking of circulating therapeutic agents in living animals

Science Translational Medicine

Volumn 5, Issue 213, 2013, Pages

  Ferguson, Brian Scott ^a,b   Hoggarth, David A ^a   Maliniak, Dan ^a   Ploense, Kyle ^a   White, Ryan J ^c   Woodward, Nick ^a   Hsieh, Kuangwen ^b   Bonham, Andrew J ^d   Eisenstein, Michael ^b   Kippin, Tod E ^a   Plaxco, Kevin W ^a   Soh, Hyongsok Tom ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b University of California   (United States)

^c UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^d METROPOLITAN STATE UNIVERSITY OF DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APTAMER; DOXORUBICIN; KANAMYCIN;

ANIMAL EXPERIMENT; ARTICLE; BIOCHIP; BIOSENSOR; BLOOD; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIFFUSION; DRUG MONITORING; FILTER; HUMAN; IN VIVO STUDY; KINETIC DIFFERENTIAL MEASUREMENT; MALE; MEASUREMENT; MICROFLUIDIC ELECTROCHEMICAL DETECTOR FOR IN VIVO CONTINUOUS MONITORING; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY AND SPECIFICITY;

ANIMALS; APTAMERS, NUCLEOTIDE; BIOSENSING TECHNIQUES; DIABETES MELLITUS; DOXORUBICIN; HUMANS; KANAMYCIN; MALE; MICROFLUIDICS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84890050288     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3007095     Document Type: Article

References (46)

1. M. A. Hamburg, F. S. Collins, The path to personalized medicine. N. Engl. J. Med. 363, 301-304 (2010).
2. D. M. Rissin, C. W. Kan, T. G. Campbell, S. C. Howes, D. R. Fournier, L. Song, T. Piech, P. P. Patel, L. Chang, A. J. Rivnak, E. P. Ferrell, J. D. Randall, G. K. Provuncher, D. R. Walt, D. C. Duffy, Single-molecule enzyme-linked immunosorbent assay detects serum proteins at subfemtomolar concentrations. Nat. Biotechnol. 28, 595-599 (2010).
3. F. Patolsky, G. Zheng, C. M. Lieber, Fabrication of silicon nanowire devices for ultrasensitive, label-free, real-time detection of biological and chemical species. Nat. Protoc. 1, 1711-1724 (2006).
4. D. A. Baker, D. A. Gough, A continuous, implantable lactate sensor. Anal. Chem. 67, 1536-1540 (1995).
5. G. S. Wilson, Y. Hu, Enzyme-based biosensors for in vivo measurements. Chem. Rev. 100, 2693-2704 (2000).
6. T. Keller, T. Zeller, D. Peetz, S. Tzikas, A. Roth, E. Czyz, C. Bickel, S. Baldus, A. Warnholtz, M. Fröhlich, C. R. Sinning, M. S. Eleftheriadis, P. S. Wild, R. B. Schnabel, E. Lubos, N. Jachmann, S. Genth-Zotz, F. Post, V. Nicaud, L. Tiret, K. J. Lackner, T. F. Münzel, S. Blankenberg, Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N. Engl. J. Med. 361, 868-877 (2009).
7. J. W. Bauer, M. Petri, F. M. Batliwalla, T. Koeuth, J. Wilson, C. Slattery, A. Panoskaltsis-Mortari, P. K. Gregersen, T. W. Behrens, E. C. Baechler, Interferon-regulated chemokines as biomarkers of systemic lupus erythematosus disease activity: A validation study. Arthritis Rheum. 60, 3098-3107 (2009).
8. M. Das Thakur, F. Salangsang, A. S. Landman, W. R. Sellers, N. K. Pryer, M. P. Levesque, R. Dummer, M. McMahon, D. D. Stuart, Modelling vemurafenib resistance in melanoma reveals a strategy to forestall drug resistance. Nature 494, 251-255 (2013).
9. P. Yager, T. Edwards, E. Fu, K. Helton, K. Nelson, M. R. Tam, B. H. Weigl, Microfluidic diagnostic technologies for global public health. Nature 442, 412-418 (2006).
10. R. S. Gaster, D. A. Hall, C. H. Nielsen, S. J. Osterfeld, H. Yu, K. E. Mach, R. J. Wilson, B. Murmann, J. C. Liao, S. S. Gambhir, S. X. Wang, Matrix-insensitive protein assays push the limits of biosensors in medicine. Nat. Med. 15, 1327-1332 (2009).
11. K. W. Plaxco, H. T. Soh, Switch-based biosensors: A new approach towards real-time, in vivo molecular detection. Trends Biotechnol. 29, 1-5 (2011).
12. B. Desoize, J. Robert, Individual dose adaptation of anticancer drugs. Eur. J. Cancer 30A, 844-851 (1994).
13. Y. Xiao, A. A. Lubin,A. J. Heeger, K.W. Plaxco, Label-free electronic detection of thrombin in blood serum by using an aptamer-based sensor. Angew. Chem. Int. Ed. Engl. 44, 5456-5459 (2005).
14. A. Wochner, M. Menger, D. Orgel, B. Cech, M. Rimmele, V. A. Erdmann, J. Glökler, A DNA aptamer with high affinity and specificity for therapeutic anthracyclines. Anal. Biochem. 373, 34-42 (2008).
15. R. F. Greene, J. M. Collins, J. F. Jenkins, J. L. Speyer, C. E. Myers, Plasma pharmacokinetics of Adriamycin and adriamycinol: Implications for the design of in vitro experiments and treatment protocols. Cancer Res. 43, 3417-3421 (1983).
16. C. Camaggi, R. Comparsi, E. Strocchi, F. Testoni, B. Angelelli, F. Pannuti, Epirubicin and doxorubicin comparative metabolism and pharmacokinetics. A cross-over study. Cancer Chemother. Pharmacol. 21, 221-228 (1988).
17. J. S. Swensen, Y. Xiao, B. S. Ferguson, A. A. Lubin, R. Y. Lai, A. J. Heeger, K. W. Plaxco, H. T. Soh, Continuous, real-time monitoring of cocaine in undiluted blood serum via a microfluidic, electrochemical aptamer-based sensor. J. Am. Chem. Soc. 131, 4262-4266 (2009).
18. J. P. Brody, P. Yager, Diffusion-based extraction in a microfabricated device. Sens. Actuators A Phys. 58, 13-18 (1997).
19. S. Eikenberry, A tumor cord model for doxorubicin delivery and dose optimization in solid tumors. Theor. Biol. Med. Model. 6, 16 (2009).
20. T. Uzawa, R. R. Cheng, R. J. White, D. E. Makarov, K. W. Plaxco, A mechanistic study of electron transfer from the distal termini of electrode-bound, single-stranded DNAs. J. Am. Chem. Soc. 132, 16120-16126 (2010).
21. Y. Ueda, K. Munechika, A. Kikukawa, Y. Kanoh, K. Yamanouchi, K. Yokoyama, Comparison of efficacy, toxicity and pharmacokinetics of free adriamycin and adriamycin linked to oxidized dextran in rats. Chem. Pharm. Bull. 37, 1639-1641 (1989).
22. A. A. Rowe, E. A. Miller, K. W. Plaxco, Reagentless measurement of aminoglycoside antibiotics in blood serum via an electrochemical, ribonucleic acid aptamer-based biosensor. Anal. Chem. 82, 7090-7095 (2010).
23. M. H. Al-Nazawi, A. M. Homeida, Comparative pharmacokinetic studies of kanamycin in camels, sheep and goats. Sci. J. King Faisal Univ. 10, 105-113 (2008).
24. D. McGregor, in Kirk-Othmer Encyclopedia of Chemical Technology (John Wiley & Sons Inc., New York, 2000).
25. N. A. Dobbs, C. J. Twelves, H. Gillies, C. A. James, P. G. Harper, R. D. Rubens, Gender affects doxorubicin pharmacokinetics in patients with normal liver biochemistry. Cancer Chemother. Pharmacol. 36, 473-476 (1995).
26. A. Elis, M. Lishner, S. Walker, D. Atias, A. Korenberg, G. Koren, Doxorubicin in lymphoma: Association between pharmacokinetic variability and clinical response. Ther. Drug Monit. 32, 50-52 (2010).
27. F. Khalil, S. Läer, Physiologically based pharmacokinetic modeling: Methodology, applications, and limitations with a focus on its role in pediatric drug development. J. Biomed. Biotechnol. 2011, 907461 (2011).
28. D. M. Bach, J. A. Straseski, W. Clarke, Therapeutic drug monitoring in cancer chemotherapy. Bioanalysis 2, 863-879 (2010).
29. W. E. Evans, M. V. Relling, J. H. Rodman, W. R. Crom, J. M. Boyett, C. H. Pui, Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. N. Engl. J. Med. 338, 499-505 (1998).
30. R. DiFrancesco, S. Rosenkranz, A. L. Mukherjee, L. M. Demeter, H. Jiang, R. DiCenzo, C. Dykes, A. Rinehart, M. Albrecht, G. D. Morse, Quality assessment for therapeutic drug monitoring in AIDS Clinical Trials Group (ACTG 5146): A multicenter clinical trial. Ther. Drug Monit. 32, 458-466 (2010).
31. A. Boyer, D. Gruson, S. Bouchet, B. Clouzeau, B. Hoang-Nam, F. Vargas, H. Gilles, M. Molimard, A. M. Rogues, N. Moore, Aminoglycosides in septic shock: An overview, with specific consideration given to their nephrotoxic risk. Drug Saf. 36, 217-230 (2013).
32. D. Gonzalez, S. Schmidt, H. Derendorf, Importance of relating efficacy measures to unbound drug concentrations for anti-infective agents. Clin. Microbiol. Rev. 26, 274-288 (2013).
33. A. D. Keefe, S. Pai, A. Ellington, Aptamers as therapeutics. Nat. Rev. Drug Discov. 9, 537-550 (2010).
34. R. D. Jenison, S. C. Gill, A. Pardi, B. Polisky, High-resolution molecular discrimination by RNA. Science 263, 1425-1429 (1994).
35. E. Pavlovic, R. Y. Lai, T. T. Wu, B. S. Ferguson, R. Sun, K. W. Plaxco, H. T. Soh, Microfluidic device architecture for electrochemical patterning and detection of multiple DNA sequences. Langmuir 24, 1102-1107 (2008).
36. C. Y. Chiang, H. G. Schneider, B. Levvey, L. Mitchell, G. I. Snell, Tacrolimus level variability is a novel measure associated with increased acute rejection in lung transplant (LTx) recipients. J. Heart Lung Transplant. 32, S170 (2013).
37. P. F. Halloran, Immunosuppressive drugs for kidney transplantation. N. Engl. J. Med. 351, 2715-2729 (2004).
38. B. V. Naidu, B. Krishnadasan, K. Byrne, A. L. Farr, M. Rosengart, E. D. Verrier, M. S. Mulligan, Regulation of chemokine expression by cyclosporine A in alveolar macrophages exposed to hypoxia and reoxygenation. Ann. Thor. Surg. 74, 899-905 (2002).
39. D. Linfert, T. Chowdhry, H. Rabb, Lymphocytes and ischemia-reperfusion injury. Transplant. Rev. 23, 1-10 (2009).
40. M. Rotondi, G. S. Netti, E. Lazzeri, G. Stallone, E. Bertoni, L. Chiovato, G. Grandaliano, L. Gesualdo, M. Salvadori, F. P. Schena, P. Romagnani, M. Serio, High pretransplant serum levels of CXCL9 are associated with increased risk of acute rejection and graft failure in kidney graft recipients. Transpl. Int. 23, 465-475 (2010).
41. T. Böhler, J. Nolting, N. Kamar, P. Gurragchaa, K. Reisener, P. Glander, H. H. Neumayer, K. Budde, J. Klupp, Validation of immunological biomarkers for the pharmacodynamic monitoring of immunosuppressive drugs in humans. Ther. Drug Monit. 29, 77-86 (2007).
42. P. A. Corris, J. A. Kirby, A role for cytokine measurement in therapeutic monitoring of immunosuppressive drugs following lung transplantation. Clin. Exp. Immunol. 139, 176-178 (2005).
43. F. H. El-Khatib, S. J. Russell, D. M. Nathan, R. G. Sutherlin, E. R. Damiano, A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci. Transl. Med. 2, 27ra27 (2010).
44. J. D. Andrade, V. Hlady, Protein adsorption and materials biocompatibility: A tutorial review and suggested hypotheses. Adv. Polym. Sci. 79, 1-63 (1986).
45. S. Koutsopoulos, L. D. Unsworth, Y. Nagai, S. Zhang, Controlled release of functional proteins through designer self-assembling peptide nanofiber hydrogel scaffold. Proc. Natl. Acad. Sci. U.S.A. 106, 4623-4628 (2009).
46. A. S. Ahuja, W. R. Hendee, P. L. Carson, Transport phenomena in laminar flow of blood. Phys. Med. Biol. 23, 928-936 (1978).